Cargando…
新辅助免疫治疗及联合化疗在NSCLC中的研究进展
Even patients after standard surgery and adjuvant chemotherapy still have a high risk of recurrence and metastasis. With the success of immunotherapy in advanced non-small cell lung cancer (NSCLC), the application of immunotherapy in locally advanced NSCLC has being investigated to reduce the recurr...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105607/ https://www.ncbi.nlm.nih.gov/pubmed/33910277 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.10 |